Legionella pneumophila Serotype 1 Pneumonia in Patient Receiving Adalimumab

We describe a case of severe pneumonia caused by Legionella pneumophila serotype 1 in a woman receiving the tumor necrosis factor–α antagonist to treat rheumatoid arthritis. As use of tumor necrosis factor–α inhibitors increase, clinicians should consider their possible association with legionellosi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wuerz, Terry C., Mooney, Owen, Keynan, Yoav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2012
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3559148/
https://www.ncbi.nlm.nih.gov/pubmed/23092579
http://dx.doi.org/10.3201/eid1811.111505
_version_ 1782257517316800512
author Wuerz, Terry C.
Mooney, Owen
Keynan, Yoav
author_facet Wuerz, Terry C.
Mooney, Owen
Keynan, Yoav
author_sort Wuerz, Terry C.
collection PubMed
description We describe a case of severe pneumonia caused by Legionella pneumophila serotype 1 in a woman receiving the tumor necrosis factor–α antagonist to treat rheumatoid arthritis. As use of tumor necrosis factor–α inhibitors increase, clinicians should consider their possible association with legionellosis.
format Online
Article
Text
id pubmed-3559148
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-35591482013-02-04 Legionella pneumophila Serotype 1 Pneumonia in Patient Receiving Adalimumab Wuerz, Terry C. Mooney, Owen Keynan, Yoav Emerg Infect Dis Dispatch We describe a case of severe pneumonia caused by Legionella pneumophila serotype 1 in a woman receiving the tumor necrosis factor–α antagonist to treat rheumatoid arthritis. As use of tumor necrosis factor–α inhibitors increase, clinicians should consider their possible association with legionellosis. Centers for Disease Control and Prevention 2012-11 /pmc/articles/PMC3559148/ /pubmed/23092579 http://dx.doi.org/10.3201/eid1811.111505 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Dispatch
Wuerz, Terry C.
Mooney, Owen
Keynan, Yoav
Legionella pneumophila Serotype 1 Pneumonia in Patient Receiving Adalimumab
title Legionella pneumophila Serotype 1 Pneumonia in Patient Receiving Adalimumab
title_full Legionella pneumophila Serotype 1 Pneumonia in Patient Receiving Adalimumab
title_fullStr Legionella pneumophila Serotype 1 Pneumonia in Patient Receiving Adalimumab
title_full_unstemmed Legionella pneumophila Serotype 1 Pneumonia in Patient Receiving Adalimumab
title_short Legionella pneumophila Serotype 1 Pneumonia in Patient Receiving Adalimumab
title_sort legionella pneumophila serotype 1 pneumonia in patient receiving adalimumab
topic Dispatch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3559148/
https://www.ncbi.nlm.nih.gov/pubmed/23092579
http://dx.doi.org/10.3201/eid1811.111505
work_keys_str_mv AT wuerzterryc legionellapneumophilaserotype1pneumoniainpatientreceivingadalimumab
AT mooneyowen legionellapneumophilaserotype1pneumoniainpatientreceivingadalimumab
AT keynanyoav legionellapneumophilaserotype1pneumoniainpatientreceivingadalimumab

Ejemplares similares